Cyclarity Therapeutics is pleased to announce regulatory approval to begin its first-in-human clinical trial. The trial will be conducted at CMAX, one of Australia’s leading clinical research centers, ...
Heart attack risks increase almost immediately during a cold snap, accounting for two in five winter excess deaths. As temperatures hit -8C or below throughout the UK, wellness specialist Brian Clarke ...
Heart disease remains a leading health issue in the UK, with seven million people affected and causing one in four premature deaths, according to the NHS ...